• In addition to an intermediary role in nucleotide synthesis and degradation, purine and pyrimidine nucleosides and bases (present as natural constituents of mammalian myocardium 1 ) have been found to exert specific physiologic effects when administered to failing 2 
"
1 and nonfailing 4 isolated hearts. In this respect, natural nucleosides and bases containing an -OH group as a substituent on the number 6 pyrimidine ring-carbon were found to be positively inotropic, while those containing an -NH-group as a substituent at this position were negatively inotropic. Since only limited information 1 "' is available concerning the cardiac metabolism of these groups of compounds, this study was undertaken.
The perfused isolated mammalian heart was employed in the studies. Nucleosides and bases to be examined contained C' ! label and were added to the perfusion medium. Since the contracting muscle was perfused under conditions controlled with respect to physical factors known to affect force of contraction, i.e., diastolic tension, afterload, and frequency of contraction, a reliable evaluation of the metabolism and inotropic activity of the administered nucleosides and bases could be made.
Twelve Langendorff preparations were made from rabbit hearts, 4 ' ° each being completed within 10 minutes after the unmedicated animal was sacrificed by a blow on the head. Immediately after excision from the thorax, the spontaneously beating heart was placed in a deep Petri dish containing warmed perfusion medium. A cannula was rapidly tied in the aorta and attached to the medium-filled perfusion circuit. 7 No more than five minutes were allowed to elapse between excision of the heart and cannulation of the aorta since rapid simulation of physiologic conditions for coronary perfusion was considered essential to the biochemical studies made. To maintain controlled conditions of physiologic performance for the duration of the experiments, the coronary circulation was perfused under constant hydrostatic pressure (35 cm H 2 O) with an oxygenated and osmotically-balanced salt-glucose medium* developed for mammalian hearts, 8 and the heart was driven electrically to contract against a constant load. The medium for all but two preparations (157 and 158) contained five units of regular insulin per liter, to promote glucose uptake. 9 The medium was also buffered to prevent undue accumulation of CO 2 produced by the contracting myocardium, and kept at a constant temperature of 33 to 35°C within 0.5°C.
Coronary drainage was collected for 30 to 60 seconds at short intervals throughout the experiments. Force of cardiac contraction was registered by a transducer consisting of a BaldwinLima strain gauge cemented onto a stiff metal bar to which the ventricular apex was attached by a short ligature. The calibrated electrical output of this transducer was recorded on a Grass model P5 polygraph at a suitable sensitivity and paper speed. Cardiac function was evaluated from contractile force developed from the diastolic level (F, grams), heart rate (HR) and coronary
•0.062 g CaCl,. 2 H 2 O, 0.042 g KC1, 0.9 g NaCI, 0.1 g glucose, and 0.08 g NaHCO.,/100 ml demineralized water. 
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TSUBOI, BUCKLEY drainage rate (CD, ml/min). The initial diastolic tension was set at 3 to 5 g.
PERFUSION TECHNIQUE
In each isotope experiment, the heart was immediately perfused with Feigen's medium until a steady state of perfusion rate was obtained, usually five minutes. Then the perfusion column was drained through a sidearm, and 30 ml of medium containing C'-labeled nucleoside or base was added. Radioactivity was at approximately 2 JXC C in each experiment,* and the concentration of nucleoside or base was adjusted by addition of unlabeled compound to the desired levels. The rapid perfusion rates in these preparations, and the intimate distribution of coronary capillaries among myocardial fibers, permitted efficient delivery of isotope throughout the contracting heart. In two preparations (128 and 129), the medium contained 235 polyvinylpyrolidone (PVP). In three preparations (154, 155, and 158), 0.2 ml of 0.1 M Na 2 HPOj was added to the medium ten minutes after the start of isotope perfusion.
Perfusate was recirculated for a fixed period of time (from 17 to 31 minutes) during which the coronary drainage was sampled for radioactivity determinations (see below). At the end of the recirculation period, the perfusate was collected and saved, and a rinse with isotope-free and nucleoside-free medium begun immediately and continued for ten minutes. During this period, the coronary drainage was sampled every two minutes again for radioactivity determinations. The "washed" heart was immediately removed, blotted, weighed, and extracted as described in the following section.
Control experiments included twelve preparat : ons perfused with Feigen's medium alone. In eight of these (six with glucose and insulin and two without), the sodium, potassium, and glucose concentrations in the perfusate were determined at intervals over a period of forty-five minutes. In both preparations, die inotropic effects of 2% PVP and of 0.1 M Na 2 HPO., were determined.
PREPARATION OF PERFUSATES AND CARDIAC EXTRACTS FOR ANALYSIS
The recirculated perfusates were concentrated by flash evaporation to dryness and redissolved in 0.1 N HC1 to a final 0.5 ml volume from which aliquots were removed for analysis. The "washed" hearts were extracted by homogenizing with nine volumes of 5% trichloroacetic acid (TCA) fol-*All purine nucleosides and bases contained C 1 -* in the number 8 ring carbon. The undine studies were carried out using uridine-2-C'->. All labeled compounds were obtained from Schwarz Bioresearch, Orangeburg, New York. lowed by filtration. Following TCA removal by repeated ether extraction, the extracts were neutralized with excess NH 4 OH, flash evaporated to dryness, and redissolved in FLO to final 0.5 ml volume. Aliquots were removed to assess losses encountered during drying (based on recovery of ultraviolet absorbing material) for quantitative purposes, and the remainder used directly for subsequent chromatographic analysis.
DETERMINATION OF DISTRIBUTION OF RADIOACTIVITY IN PERFUSATES AND CARDIAC EXTRACTS
Prepared samples of the perfusates were chromatographed by applying aliquots (100 A) to strips of Whatmann 3MM paper (2.5 cm X 50 cm) and developing 16 hours in our solvent IV (water-saturated butanol, containing excess solid NH 4 HCO 3 ) system.
1 " Separated radioactive deposits were identified and located by co-chromatography with added known compounds, and visualized with a mineralight ultraviolet lamp. Quantitative radioactive distribution was carried out by cutting the entire paper strip into 3.5 cm lengths and counting in a Parkard tri-carb liquid scintillation counter by immersion in a vertical position in 15 ml of liquid scintillation counting medium (0.5$ 2, 5diphenyloxazole) plus 0.03% 1, 4-bis-2-(4-methyl-5-phenyIoxazoly-benzene in toluene).
Analyses of the cardiac extracts were carried out in two steps. Aliquots of the dried and redissolved extracts were initially chromatographed in Whatmann 3MM paper using our solvent IV system as with the perfusates. The selected solvent separates nucleosides and bases which are mobile from the nucleotides remaining at the origin as a group. 10 Distribution of radioactivity among the nucleosides, bases, and the total nucleotides as a group, resulting from this initial chromatographic separation, was determined according to the methods described for the perfusates. The second part of the analysis involved evaluation of label distribution among the various cardiac nucleotide components. The nonmobile nucleotides remaining as a group at the origin, following solvent IV development, were eluted (water) and again concentrated to dryness by flash evaporation. The dried nucleotide fractions were redissolved and aliquots subjected to hydrolysis by heating for one hour in a boiling water bath in the presence of 0.1 N HC1; thereby liberating all purine bases from glycosidic linkage. The resulting purine bases (of nucleotide origin) were subsequently resolved by chromatography (solvent IV) and associated radioactivity assessed according to the methods described for the perusates.
In a few cases, distribution of radioactivity was further assessed among individual nucleotide components. In these cases, aliquots of the re- dissolved nucleotide fractions were either spotted directly on Whatmann 3MM paper sheets (18 X 22 inches), or following preliminary isolation on Norite, 10 and subjected to two-dimensional chromatography to effect resolution of individual nucleotide components. 10 ' n Detection of radioactivity among the separated nucleotides was accomplished by radio-autographic technique. Identification of nucleotides in a uridine-C' J study was based on coincidence of radioactivity with added nonlabeled standard materials. 10 Radioactivity associated with nucleotides was quantitatively determined in this study according to the procedure described for the perfusates. Distribution of C fi among adenine nucleotides, following adenine-C u perfusion, was determined by liquid scintillation counting of the eluted nucleotide deposits. 
Recordings of cardiac contractions in representative experiments with labeled nucleosides and bases. (A) before administration of labeled compound; (B) during perfusion of labeled compound; and (C) fol

lnosine-C'-i perfusion experiments. (A) perfusion in the presence of glucose and instdin; (B) perfusion in the absence of glucose and instilin; and (C) perfusion in the presence of glucose and instdin plus phosphate. Radioactivity was monitored in the reciradated perftisate and wash medium over the indicated time intervah.
glucose consumption, and extracellular sodium and potassium concentrations could be maintained throughout the forty-minute test period employed during recirculation of saltglucose medium. When no glucose was available, contractile force diminished continuously. In further control experiments, it was found that the addition of PVP or Na 2 HPO 4 (in the concentrations used in selected isotope studies) did not affect contractile force or coronary drainage rate.
l»orop« Experiment! Figure 1 presents polygraph records from two typical isotope experiments, illustrating the level of physiologic performance and the inotropic responses obtained. The values for contractile force, heart rate, and coronary drainage rates were in the range usually obtained with fresh Langendorff preparations in our laboratory. 4 Force of cardiac contraction was increased in the presence of inosine, uridine, guanosine and hypoxanthine ( fig. IB,  top) , while it was decreased in the presence of adenine ( fig. IB, bottom) . These inotropic effects were identical to previously reported effects of single doses of nucleosides or bases on similar cardiac preparations. 4 In all experiments in which the perfusion medium contained glucose and insulin, excepting the hypoxanthine experiments (159 and 162), inotropic activity was either continuously maintained or gradually increased throughout the period of recircuJation of C " labeled compound. Force of cardiac contraction in the hypoxanthine experiments, on the other hand, increased during the first ten minutes but decreased to the control level by the end of the recirculation period. In the two experiments using inosine C H , in the absence of glucose and insulin, the positive inotropic activity was also short-lived. All hearts appeared to return to a control level of function, or better, during the washout period, and to be in good condition prior to preparation of the muscle extracts (see fig. 1C ).
LABELED NUCLEOSIDE AND BASE PERFUSION CHARACTERISTICS Ctneral
Perfusion of the various labeled nucleosides and bases examined in the present studies resulted in generally similar patterns of isotope removal from the perfusion medium by the isolated heart. Typical patterns obtained are illustrated in figure 2 , in which the results of various labeled inosine perfusions are presented as examples. The efficiency of the "wash" procedure in effecting removal of excess label, i.e., perfused labeled inosine, from the preparations is also indicated from the illustrated results.
Consideration of Ponlble Factora Affecting Uptak*
Perfusion of labeled nucleosides and bases resulted in an initial sharp drop in their concentrations in the perfusion media ( fig. 2) , attributed primarily to dilution by tissue water. Following the initial drop, a slower, generally constant uptake of the labeled compounds by the hearts occurred during the remaining perfusion periods. Possible factors affecting nucleoside uptake by the heart were examined in conjunction with the labeled inosine studies. Since stimulation of purine nucleoside utilization by intact erythrocytes has been obtained in the presence of Pi (K. K. Tsuboi, unpublished observations), the possibility of a similar stimulation was examined with the heart. As shown in figure 2, curve B, labeled inosine perfusion in the presence of added inorganic orthophosphate (P|) did not stimulate further label uptake by the heart. Deletion of glucose from the perfusion medium (as a possible competing source of carbohydrate with the ribose moiety of inosine) was also tested and found to show little effect on the rate of inosine removal from the medium by the heart ( fig. 2 , curve C).
METABOLISM OF LABELED NUCLEOSIDES AND BASES Inoilne-C*
Perfusion of labeled inosine was carried out under a variety of conditions including the presence and absence of glucose-insulin and P] (table 1) . Values representing labeled inosine conversion to nucleotides in each of the experiments have been summarized and included in table 1. Conversion to nucleotide was generally low and did not appear to be greatly affected by the variations introduced in the perfusion media.
Analyses of perfusates and cardiac extracts resulting from the labeled inosine perfusion experiments detailed in table 1 have been summarized in table 2. The perfusates were found to contain, in addition to the labeled inosine, large amounts of hypoxanthine, suggesting the result of considerable degradative action by nucleoside phosphorylase 12 (presumably following inosine entry into the cells with subsequent hypoxanthine exit into the medium). No other labeled materials were found to be present in the perfusates. Analyses of the cardiac extracts showed associated radioactivity to be limited to inosine, hypoxanthine and nucleotides. Proportionately greater amounts of hypoxanthine than inosine were found in the heart extracts when compared with their relative presence in the perfusates, suggesting their unequal cellular retention due to differences in permeability. Incorporation of radioactivity into nucleotides was further assessed and found to be distributed in the adenine and guanine nucleotides in addition to inosinic acid (IMP).
Uridln«-C'l
The metabolism of uridine, a previously established positive inotropic agent, was examined in four experiments using various uridine concentrations as shown in table 3. Perfusion of isolated heart preparations with labeled uridine results in incorporation of the label into the uridine nucleotides in the amounts shown (table 3) . Analysis of the resulting perfusates indicated the presence of small amounts of labeled uracil, which with the % of total*
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*These values refer to percentages of the total nucleotide radioactivity associated with each of the isolated bases. *These values refer to percentages of the total nucleotide radioactivity found with the isolated hydrolyzed products, i.e., purine bases and uridine monophosphate (UMP). •Resolution of uracil compounds achieved by two-dimensional paper chromatography. 10 IdentiBcation and localization of the minor labeled uracil containing compounds was achieved by co-chromatography in the presence of added standard materials (UMP, UDP, UTP, UDPG) and subsequent radioautography (four to six months). Compound designated as UDPX is presumed to be UDPGAL. added uridine accounted entirely, i.e., within our experimental limits, for all radioactivity present (table 4). Examination of the prepared extracts of the perfused (and "washed") hearts, showed the presence of radioactivity associated with uridine, uracil and uridine nucleotides. The ratio of uracil to uridine in these extracts exceeded that present in the perfusates, indicating (as with inosine and hypoxanthine) unequal cellular retention of the base and nucleoside presumably due to differences in permeability (table  4) . Lable incorporation into the cardiac nucleotide fraction was limited solely to the uridine nucleotides insofar as detectable within our experimental limits (tables 4 and 5).
Guanoslne-C"
Cardiac metabolism of guanosine was examined in a single perfusion experiment summarized in table 6. Perfused guanosine was found to be incorporated to a limited extent into cardiac nucleotides. The perfused guanosine was partially degraded to guanine and a further unidentified product in the perfusate. The heart extract was free of detectable labeled guanine but did contain guanosine as the only labeled nonnucleotide component. Analyses of the nucleotide base components of the extract showed radioactivity to be associated only with guanine. Significant interconversion leading to incorporation of the label into other nucleotides, i.e., of adenine and IMP did not occur within the experimental time period employed. poxanthine (a positive inotrope) and adenine (a negative inotrope) was also examined as a part of the present study. The perfusion conditions employed in each of the experiments are summarized in table 7. The extent of perfused base incorporation into cardiac nucleotides is also shown in table 7. Perfusates resulting from the labeled adenine and inosine perfusions contained, in addition to the added purine, measurable quantities of labeled products as shown in table 8. Although conversion of perfused labeled adenine to hypoxanthine was evident in the perfusates, the converse was not demonstrated. The perfusates contained significant amounts of other labeled products which were not thoroughly identified. Examination of the cardiac extracts following labeled hypoxanthine or adenine perfusion indicated variable retention of the perfused compounds by the hearts (table 8) . Some interconversion of the perfused compounds appeared to occur in the hearts. Significant quantities of unidentified, labeled, nonnucleotide products were also found in each of the extracts examined. Label incorporation into cardiac nucleotides was localized primarily to the adenine nucleotides, in the case of both labeled adenine and hypoxanthine perfusions. Relative C' 4 distribution among the purine nucleotide bases (table 8) and specific activities of isolated nucleotides (table 9) , following labeled adenine perfusion were examined. In addition to the adenine nucleotides, guanine nucleotides as well as IMP were found to be labeled. The adenine nucleotides showed equivalent C* distribution among adenosine monophosphate (AMP), adenosine diphosphate (ADP) and adenosine triphosphate (ATP). This supports the view that they exist intracellularly in equilibria. Lesser label incorporation was found in diphosphopyridine nucleotide (DPN) as well as IMP. Specific activity of guanine nucleotides was not assessed due to their limited presence.
Discussion
Cardiac metabolism of those nucleosides and bases having positive inotropic activity (i.e., inosine, uridine, guanosine, and hypox- 
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TABLE 7
Hypoxanthine-C'i and Adenine-C$ Perfusion Conditions and Incorporation into Nucleotides
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•/. of total 10 3 4 Cuan. 8 7 *These values refer to percentages of total nucleotide radioactivity found with each of the derived bases (by hydrolysis). anthine, all containing -OH substitution on the number 6 carbon of the pyrimidine ring) was examined in the present study. In view of considerable difficulty maintaining viable cardiac preparations in the presence of those nucleosides and bases demonstrating negative inotropic activity, i.e., adenosine, cytidine, cytosine, and adenine, all containing -NH 2 substitution on the number 6 carbon of the pyrimidine ring, only adenine metabolism was examined among this latter group of compounds.
The metabolism of administered nucleosides and bases by the mammalian heart followed generally predictable sequences in each case. The presence of functional so-called salvage pathways 13 leading to preformed base incorporation into cardiac nucleotides could be demonstrated with each of the tested compounds. Partial degradation of the tested nucleosides (inosine, guanosine, uridine) occurred, leading to the liberation of the corresponding free bases, presumably as the result of purine 12 u and pyrimidine 1 r ' nucleoside phosphorylase action. Since C" incorporation into nucleotide did not differ greatly on administration of either labeled inosine or hypoxanthine, glycosylation of the free base by ribose-l-pyrophosphate-5-phosphate 10 (PRPP) was the most probable mechanism leading to the synthesis of the purine nucleotides. Labeled inosine and hypoxanthine administration resulted in the distribution of the label among the various cardiac purine nucleotides in accord with known biosynthetic pathways leading initially to inosinic acid (IMP) formation 1 " with subsequent conversion of IMP to adenosine monophosphate (AMP) by amination 17 or guanosine monophosphate (GMP) by oxidation 18 and amination.
10 C' -* distribution among cardiac nucleotides resulting from labeled adenine perfusion was consistent with the following sequence: initial glycosylation of adenine by PRPP to yield AMP, 1 " equilibration with ADP and ATP by myokinase action, 11 conversion to IMP by possible AMP deaminase action and further conversion of the IMP to GMP. 18 ' 10 Labeled guanosine perfusion, on the other hand, resulted in label incorporation in the guanine nucleotides only, indicating an inability of the heart to transform GMP to IMP 20 and therefore, an inability to freely interconvert GMP and AMP. Uridine conversion to nucleotide in the mammalian heart occurs either directly by (a) uridine phosphokinase action, 15 or following base liberation 1 " by (b) glycosylation of the uracil by PRPP, 1S with either reaction yielding uridine monophosphate (UMP). Further distribution of label among the various uridine polyphos-Recirculation of C'Mabeled hypoxanthine or adenine was accompanied by incorporation of radioactivity into cardiac purine nucleotides. Equivalent label distribution was found among adenosine monophosphate, adenosine diphosphate, and adenosine triphosphate, indicating intracellular equilibrium among these compounds. Conversion of labeled adenine to hypoxanthine occurred in the perfusate of the adenine-C 14 experiments. The cardiac metabolism of the perfused nucleosides and bases followed generally predictable sequences, and did not suggest a mechanism for the marked inotropic activity of these compounds.
